As of 2025-07-04, the EV/EBITDA ratio of Medipharm Labs Corp (LABS.TO) is -3.15. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. LABS.TO's latest enterprise value is 20.74 mil CAD. LABS.TO's TTM EBITDA according to its financial statements is -6.59 mil CAD. Dividing these 2 quantities gives us the above LABS.TO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.6x - 17.9x | 14.8x |
| Forward P/E multiples | 14.9x - 25.2x | 20.0x |
| Fair Price | (0.22) - (0.26) | (0.26) |
| Upside | -409.8% - -477.4% | -466.1% |
| Date | EV/EBITDA |
| 2025-07-02 | -3.15 |
| 2025-06-30 | -3.15 |
| 2025-06-27 | -3.15 |
| 2025-06-26 | -3.46 |
| 2025-06-25 | -3.46 |
| 2025-06-24 | -3.46 |
| 2025-06-23 | -3.46 |
| 2025-06-20 | -3.46 |
| 2025-06-19 | -3.46 |
| 2025-06-18 | -3.78 |
| 2025-06-17 | -3.78 |
| 2025-06-16 | -3.78 |
| 2025-06-13 | -4.09 |
| 2025-06-12 | -4.09 |
| 2025-06-11 | -3.78 |
| 2025-06-10 | -3.78 |
| 2025-06-09 | -3.78 |
| 2025-06-06 | -3.78 |
| 2025-06-05 | -3.15 |
| 2025-06-04 | -3.46 |
| 2025-06-03 | -3.46 |
| 2025-06-02 | -3.46 |
| 2025-05-30 | -3.46 |
| 2025-05-29 | -3.15 |
| 2025-05-28 | -3.46 |
| 2025-05-27 | -3.46 |
| 2025-05-26 | -3.78 |
| 2025-05-23 | -3.46 |
| 2025-05-22 | -3.78 |
| 2025-05-21 | -3.15 |
| 2025-05-20 | -3.78 |
| 2025-05-16 | -4.41 |
| 2025-05-15 | -4.72 |
| 2025-05-14 | -5.04 |
| 2025-05-13 | -4.72 |
| 2025-05-12 | -4.41 |
| 2025-05-09 | -4.25 |
| 2025-05-08 | -4.72 |
| 2025-05-07 | -4.09 |
| 2025-05-06 | -4.09 |
| 2025-05-05 | -4.41 |
| 2025-05-02 | -4.09 |
| 2025-05-01 | -4.09 |
| 2025-04-30 | -4.41 |
| 2025-04-29 | -4.09 |
| 2025-04-28 | -4.41 |
| 2025-04-25 | -4.41 |
| 2025-04-24 | -4.41 |
| 2025-04-23 | -4.09 |
| 2025-04-22 | -4.41 |